Thank you for downloading the white paper: "Chemical Inhibitors to RAS Oncoproteins"

As a new Ebola outbreak emerges, research into this devastating disease continues to accelerate. Discover how scientists are developing vaccines and therapeutics while confronting the challenge of sustaining innovation between crises.

Three experts from CAS, the University of Messina, and the Coriell Institute break down how epigenetics has evolved from a niche research area into a clinical force, with 13 FDA-approved drugs, 2,200+ active trials, and a fast-growing diagnostic toolkit reshaping how we detect and treat cancer.

Highlights from a recent CAS Insights webinar on AI in medicinal chemistry. How CAS BioFinder was used to assist in target prediction for bioactive compounds.